QualityStocks'  Instablog

QualityStocks
Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
QualityStocks
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • International Stem Cell Corp. (ISCO) To Present Data From Parkinson's Disease Program At American Neurological Association Annual Meeting 0 comments
    Sep 25, 2013 10:27 AM | about stocks: ISCO

    International Stem Cell Chief Scientific Officer Dr. Ruslan Semechkin is scheduled to present the company's latest results from its Parkinson's disease program at the American Neurological Association's 2013 Annual Meeting October 13 - 15, 2013, in New Orleans.

    Dr. Semechkin's presentation will be conducted in collaboration with the Sanford Burnham Medical Research Institute, and detail new data and results from ISCO's first primate study, which includes an outline of neural stem cells' unique mechanism of action, data on the fate of the cells, and a detailed analysis of the primate's immune response to the implantation.

    The presentation will be at the following session:

    Date: Monday, October 14, 2013

    Time: 11:00 am - 7:00 pm

    Title: The Use of Neural Stem Cells for the Treatment of Parkinson's Disease in a Non-Human Primate Model

    ISCO's Parkinson's disease program uses human parthenogenetic neural stem cells (hPNSC), a novel therapeutic cellular product derived from the company's proprietary histocompatible human pluripotent stem cells.

    hPNSC are self-renewing multipotent cells that are precursors for the major cells of the central nervous system. The cells have several characteristics that the company believes offer a new and revolutionary opportunity for the treatment of Parkinson's disease, especially in cases where current dopamine-replacement approaches fail to adequately control the symptoms. hPNSC are able to differentiate into dopaminergic neurons and are able to express neurotrophic factors such as glial derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF) to protect the nigrostriatal system.

    For more information, visit internationalstemcell.com

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

    Stocks: ISCO
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.